These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31876322)

  • 1. Comparison of abacavir-specific effector and proliferating functions of CD8 T cells in abacavir-treated HIV-1 patients.
    Faridi RM; Patel S; Dharmani-Khan P; Gill J; Berka N; Khan FM
    Microbiol Immunol; 2020 Mar; 64(3):210-218. PubMed ID: 31876322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced alloreactivity: A new paradigm for allorecognition.
    D'Orsogna LJ; Almeida CM; van Miert P; Zoet YM; Anholts JDH; Chopra A; Watson M; Witt C; John M; Claas FHJ
    Am J Transplant; 2019 Sep; 19(9):2606-2613. PubMed ID: 31125485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
    King D; Tomkins S; Waters A; Easterbrook PJ; Thurmond LM; Thorborn DE; Raffi F; Kemeny DM; Vyakarnam A
    J Allergy Clin Immunol; 2005 May; 115(5):1081-7. PubMed ID: 15867870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profiling in abacavir hypersensitivity patients.
    Almeida CA; Martin AM; Nolan D; Lucas A; Cameron PU; James I; Phillips E; Mallal S
    Antivir Ther; 2008; 13(2):281-8. PubMed ID: 18505179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abacavir-reactive memory T cells are present in drug naïve individuals.
    Lucas A; Lucas M; Strhyn A; Keane NM; McKinnon E; Pavlos R; Moran EM; Meyer-Pannwitt V; Gaudieri S; D'Orsogna L; Kalams S; Ostrov DA; Buus S; Peters B; Mallal S; Phillips E
    PLoS One; 2015; 10(2):e0117160. PubMed ID: 25674793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.
    Naisbitt DJ; Yang EL; Alhaidari M; Berry NG; Lawrenson AS; Farrell J; Martin P; Strebel K; Owen A; Pye M; French NS; Clarke SE; O'Neill PM; Park BK
    AIDS; 2015 Nov; 29(18):2385-95. PubMed ID: 26372480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
    Mallal S; Nolan D; Witt C; Masel G; Martin AM; Moore C; Sayer D; Castley A; Mamotte C; Maxwell D; James I; Christiansen FT
    Lancet; 2002 Mar; 359(9308):727-32. PubMed ID: 11888582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
    Chessman D; Kostenko L; Lethborg T; Purcell AW; Williamson NA; Chen Z; Kjer-Nielsen L; Mifsud NA; Tait BD; Holdsworth R; Almeida CA; Nolan D; Macdonald WA; Archbold JK; Kellerher AD; Marriott D; Mallal S; Bharadwaj M; Rossjohn J; McCluskey J
    Immunity; 2008 Jun; 28(6):822-32. PubMed ID: 18549801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
    Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
    J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abacavir hypersensitivity reaction in primary HIV infection.
    Stekler J; Maenza J; Stevens C; Holte S; Malhotra U; McElrath MJ; Corey L; Collier AC
    AIDS; 2006 Jun; 20(9):1269-74. PubMed ID: 16816555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
    Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
    Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of abacavir hypersensitivity by ELISpot method.
    Esser S; Jablonka R; Heinemann FM; Reuter S; Jaeger H; von Krosigk A; Schenk-Westkamp P; Schadendorf D; Horn PA; Lindemann M
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):227-34. PubMed ID: 22338581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.
    Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F
    Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.
    Small CB; Margolis DA; Shaefer MS; Ross LL
    BMC Infect Dis; 2017 Apr; 17(1):256. PubMed ID: 28399804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity determines T-cell reactivity in abacavir hypersensitivity.
    Adam J; Eriksson KK; Schnyder B; Fontana S; Pichler WJ; Yerly D
    Eur J Immunol; 2012 Jul; 42(7):1706-16. PubMed ID: 22585534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome.
    Fodor J; Riley BT; Kass I; Buckle AM; Borg NA
    Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity.
    Schnyder B; Adam J; Rauch A; Thurnheer MC; Pichler WJ
    J Allergy Clin Immunol; 2013 Sep; 132(3):756-758. PubMed ID: 23706613
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.
    Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ
    Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.
    Adam J; Wuillemin N; Watkins S; Jamin H; Eriksson KK; Villiger P; Fontana S; Pichler WJ; Yerly D
    PLoS One; 2014; 9(4):e95339. PubMed ID: 24751900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful translation of pharmacogenetics into the clinic: the abacavir example.
    Phillips E; Mallal S
    Mol Diagn Ther; 2009; 13(1):1-9. PubMed ID: 19351209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.